MedPath

Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis

Completed
Conditions
Gambling Disorder
Psychotic Disorders
Interventions
Drug: Antipsychotic use
Other: Psychiatric comorbidities
Other: Sociodemographics/socioeconomic status
Other: Gambling history
Other: Clinical variables
Registration Number
NCT05686772
Lead Sponsor
Laval University
Brief Summary

The aims of this propsective cohort study are to get a better understanding of the association between problem gambling and psychotic disorders among young adults with first-episode psychosis.

The main questions to be answered are:

1. What is the incidence of problem gambling in this population?

2. What are the predictors of problem gambling in this population?

To do so, putative predictors of problem gambling will be analyzed using Cox regression models:

* Sociodemographics (e.g., age, gender identity, ethnicity, level of education, employment);

* Psychiatric comorbidities (e.g., substance use disorders, cluster B personality disorders);

* Antipsychotic use (first/second-generation, third-generation \[aripiprazole, brexpiprazole, cariprazine\]);

* Prior gambling history.

Detailed Description

All Cox regression models will be adjusted for site-effect. Further multivariable models will be constructed to examine the association between antipsychotic use (as continuous exposure) and incident PBG using the directed acyclic graphs approach to adjust for confounders.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
520
Inclusion Criteria
  • 18 to 35 years old;
  • Diagnosis of first-episode psychosis (i.e., DSM-5 diagnosis of schizophrenia spectrum and other psychotic disorders, as well as DSM-5 bipolar disorder with psychotic features).
Exclusion Criteria
  • Active/prior PBG at te time of admission;
  • Loss to follow-up within first three months;
  • DSM-5 diagnosis of psychotic disorder due to a medical condition;
  • Severe intellectual disability.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
First-episode psychosis patientsAntipsychotic useAll patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.
First-episode psychosis patientsPsychiatric comorbiditiesAll patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.
First-episode psychosis patientsSociodemographics/socioeconomic statusAll patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.
First-episode psychosis patientsGambling historyAll patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.
First-episode psychosis patientsClinical variablesAll patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.
Primary Outcome Measures
NameTimeMethod
Problem gamblingOutcome assessed at every 6-month time point, from patients admission until the first occurrence of the primary outcome, loss to follow-up, or May 1, 2023.

i) Diagnosis of gambling disorder according to DSM-5 criteria, established by the treating psychiatrist, and/or; ii) Problem gambling according to a score of 8 and more on the Problem Gambling Severity Index, as questioned by the clinical case manager and/or treating psychiatrist

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Montreal University Hospital Center

🇨🇦

Montreal, Quebec, Canada

Quebec Mental Health University Institute

🇨🇦

Quebec, Canada

Montreal University Hospital Center
🇨🇦Montreal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath